Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,651–6,675 of 27,380 studies, newest first · page 267 of 1096.

April 2024 25

  1. 2024-04-16

    A Review of Recent Advances in the Management of Alzheimer's Disease

    ✓ Peer-reviewed Drug development Cureus

    Key finding: The antidiabetic drugs include NE3107, an anti-inflammatory and insulin sensitizer, and the diabetes mainstream drug metformin. +4 more findings

  2. 2024-04-16

    Mediterranean diet protects against a neuroinflammatory cortical transcriptome: Associations with brain volumetrics, peripheral inflammation, social isolation, and anxiety in nonhuman primates (Macaca fascicularis)

    ✓ Peer-reviewed Prevention trials Brain, behavior, and immunity

    Key finding: We assessed the effects of Western versus Mediterranean-like diets on RNAseq-generated transcriptional profiles in lateral temporal cortex and their relationships with longitudinal changes in neuroanatomy, circulating monocyte gene expression, and observations of social isolation and anxiety in 38 socially-housed, middle-aged female cynomolgus macaques (Macaca fascicularis). +4 more findings

  3. 2024-04-16

    Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Higher baseline p-tau181 and NfL were associated with significantly faster decline in most cognitive, physical, and functional outcomes (+1 SD p-tau181: β MMSE = -0.055, 95% CI -0.067 to -0.043, β FCSRT = -0.034, 95% CI -0.043 to -0.025, β fluency = -0.029, 95% CI -0.038 to -0.020, β SPPB = -0.040, 95% CI -0.057 to -0.022, and β 4IADL = -0.115, 95% CI 0.091-0.140. +1 SD NfL: β MMSE = -0.039, 95% CI -0.053 to -0.025, β FCSRT = -0.022, 95% CI -0.032 to -0.012, β fluency = -0.014, 95% CI -0.024 to -0.004, and β 4IADL = 0.077, 95% CI 0.048-0.105). +3 more findings

  4. 2024-04-15
  5. 2024-04-15

    Predicting Driving Cessation Among Cognitively Normal Older Drivers: The Role of Alzheimer Disease Biomarkers and Clinical Assessments

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: With the aging US population and increasing incidence of Alzheimer disease (AD), understanding factors contributing to driving cessation among older adults is crucial for clinicians. +3 more findings

  6. 2024-04-14

    Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: In general linear models lower plasma Aβ42/40 was related to lower visuospatial ability, higher total tau was related to lower episodic memory, and higher NfL was related to lower visuospatial ability and lower episodic memory. +2 more findings

  7. 2024-04-14

    Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: These findings show how online testing can now be deployed in patients with AD to measure cognitive function effectively and related to blood biomarkers of the disease. +3 more findings

  8. 2024-04-13

    α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway

    ✓ Peer-reviewed Disease mechanisms Cell death & disease

    Key finding: We report that either αSyn overexpression or αSyn pre-formed fibrils (PFFs) treatment triggers the formation of cofilin-actin rods, synapse disruptors, in cultured hippocampal neurons and in the hippocampus of synucleinopathy mouse models and of LBD patients. +4 more findings

  9. 2024-04-12

    Mason Caregivers Aiming for Resilience, Empowerment, and Support Study: Assessing Family Caregiver Burden Post-Intervention

    ✓ Peer-reviewed Caregiving Journal of applied gerontology : the official journal of the Southern Gerontological Society

    Key finding: Family caregivers of older adults living with severe dementia had the highest baseline Zarit Burden Interview (ZBI) score of 27.7 which decreased to 25.0 (p < .05); family caregivers of those living with moderate dementia had a baseline ZBI score of 24.3 which decreased to 20.4 (p < .01); and family caregivers of those living with mild dementia had the lowest baseline ZBI score of 21.0, which decreased to 18.0 (p < .01). +1 more finding

  10. 2024-04-12

    Effects of APOE4 on omega-3 brain metabolism across the lifespan

    ✓ Peer-reviewed Prevention and risk Trends in endocrinology and metabolism: TEM

    Key finding: Omega-3 (n-3) polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (DHA), have important roles in human nutrition and brain health by promoting neuronal functions, maintaining inflammatory homeostasis, and providing structural integrity. +2 more findings

  11. 2024-04-12

    SHIP inhibition mediates select TREM2-induced microglial functions

    ✓ Peer-reviewed TREM2 and immune genetics Molecular immunology

    Key finding: The R47H variant of TREM2 has emerged as a significant genetic risk factor for AD, leading to a loss-of-function phenotype in mouse AD models. +3 more findings

  12. 2024-04-12

    Alzheimer's disease cerebrospinal fluid biomarkers and kidney function in normal and cognitively impaired older adults

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: Lower estimated glomerular filtration rate (eGFR) was associated with lower amyloid beta (Aβ)42/tau ratio (p < 0.0001) and Aβ42 (p = 0.002) and higher tau (p < 0.0001) and p-tau (p = 0.0002). +4 more findings

  13. 2024-04-12

    Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population

    ✓ Peer-reviewed Biomarkers Psychiatry and clinical neurosciences

    Key finding: During the follow-up, 151 participants developed dementia, of whom 108 had Alzheimer disease (AD) and 43 non-Alzheimer dementia (non-AD). +4 more findings

  14. 2024-04-12

    Neurofilaments as biomarkers in neurological disorders - towards clinical application

    ✓ Peer-reviewed Biomarkers Nature reviews. Neurology

    Key finding: Progress has now moved the measurement of neurofilaments to the doorstep of routine clinical practice for the evaluation of individuals. +4 more findings

  15. 2024-04-11

    Antiarrhythmic effects of metformin

    ✓ Peer-reviewed Drug development Heart rhythm O2

    Key finding: Atrial fibrillation/flutter (AF) is a major public health problem and is associated with stroke, heart failure, dementia, and death. +4 more findings

  16. 2024-04-11

    Tear biomarkers

    ✓ Peer-reviewed Brain scans and imaging Advances in clinical chemistry

    Key finding: Pooled versus single-tear analysis is discussed to underline the benefits and challenges associated with both approaches, offering insights into optimal strategies for tear sample analysis. +1 more finding

  17. 2024-04-10

    Sex differences in interacting genetic and functional connectivity biomarkers in Alzheimer's disease

    ✓ Peer-reviewed Brain scans and imaging GeroScience

    Key finding: Prior research indicates that AD disproportionality affects females; females have a greater incidence rate, perform worse on a variety of neuropsychological tasks, and have greater total brain atrophy. +2 more findings

  18. 2024-04-10

    Cortical Tau Aggregation Patterns associated with Apraxia in Alzheimer's Disease

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging medRxiv : the preprint server for health sciences

    Key finding: We identified significant clusters of tau-aggregation in praxis-related regions (e.g., supramarginal gyrus, angular gyrus, temporal, parietal and occipital regions) that were associated with apraxia. +3 more findings

    Scored 28 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2024-04-10

    Long‐term outcomes after rehabilitation in Medicare Advantage and fee‐for‐service beneficiaries

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Geriatrics Society

    Key finding: Among 738 MA and 1488 FFS participants, weighted mean age was 76 years (SD 7.0), 59% were female, and 9% had probable dementia. +4 more findings

  20. 2024-04-10

    Rare genetic variation in fibronectin 1 (FN1) protects against APOEε4 in Alzheimer's disease

    ✓ Peer-reviewed Genetics Acta Neuropathologica

    Key finding: The risk of developing Alzheimer's disease (AD) significantly increases in individuals carrying the APOEε4 allele. +4 more findings

  21. 2024-04-09

    Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study

    ✓ Peer-reviewed Genetics Neurology and therapy

    Key finding: Our TSMR analysis showed a significant positive association between genetic predisposition to methotrexate use and dementia risk. +4 more findings

  22. 2024-04-09

    Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia

    ✓ Peer-reviewed Biomarkers Frontiers in endocrinology

    Key finding: GFAP, NfL and pTau 181 levels in plasma were lower in SCD and MCI than in AD patients. +3 more findings

  23. 2024-04-09

    Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers

    ✓ Peer-reviewed Tau biomarkers BMC neurology

    Key finding: The authors sought to examine the impact of the K-variant of butyrylcholinesterase (BCHE-K) carrier status on age-at-diagnosis of Alzheimer disease (AD) in APOE4 carriers. +3 more findings

  24. 2024-04-09
  25. 2024-04-08

    Atrial Fibrillation and Dementia: Pathophysiological Mechanisms and Clinical Implications

    ✓ Peer-reviewed Risk factors Biomolecules

    Key finding: Individuals with atrial fibrillation are at higher risk of dementia and cognitive dysfunction, as atrial fibrillation increases the risk of cerebral hypoperfusion, inflammation, and stroke.

Browse the library by subject, with the full score breakdown →